CEO, Cardeas Pharma
Sector Expertise: Biopharmaceuticals
An MD Pulmonologist/ Internist, Dr. Montgomery led translational research at Genentech. He was EVP of R&D and Regulatory Affairs at PathoGenesis, before founding Corus Pharma (acquired by Gilead Sciences in 2006). Post acquisition, he was Senior VP and head of Respiratory Therapeutics at Gilead. He has led six new drugs through FDA approval. The Seattle Post Intelligencer named him one of the three most influential leaders in Seattle’s biotech industry. Dr. Montgomery has been a director for a number of local Biotechs, including Geospiza, Light Sciences Corporation, Zymogenetics, Alder and M3 biopharma. His trustee roles have included the Life Science Discovery Fund, the Army Science Board, and the Pacific Science Center. He is currently the CEO of Cardeas Pharma.